Pillar Guide
GLP-1 Side Effects & Safety
GLP-1 side effects, safety data, contraindications and symptom management, explained for patients from FDA and peer-reviewed sources.
No guide in this pillar makes a claim without a source behind it — FDA documents, trial reports, peer-reviewed papers. Both are laid out, in our methodology and the full central citation registry.
Start here
Guides in this pillar
Compounded Semaglutide: Is It Safe? What to Know in 2026
A sourced guide to compounded semaglutide safety: FDA's stance, 503A vs 503B pharmacies, what to look for in a provider, and red flags to walk away from.
Updated October 30, 2026
How to Manage Semaglutide Side Effects, From Nausea to Constipation
A sourced guide to semaglutide side effects (nausea, constipation, fatigue, gallbladder, pancreatitis), with practical management steps and red flags.
Updated October 30, 2026
Ozempic and Gallbladder Issues: What the Research Actually Shows
The elevated risk of gallbladder disease on GLP-1 drugs: what the JAMA meta-analysis found, why it happens, and who's at higher risk.
Updated October 15, 2026
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory